Keywords: pharming, prodarsan, completes, ph, trial, dutch, biotechnology

Pharming's Prodarsan completes Ph I trial

Article | 01 December 2008

Print This

Dutch biotechnology firm Pharming Group NV says that its wholly-owned subsidiary DNage has successfully completed a Phase I trial in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in